✦ LIBER ✦

Banishing levodopa-induced dyskinesia

Book ID: 120859527
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200313940-00014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa-induced dyskinesia

✍ Agid Yves 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Levodopa-induced dyskinesias

✍ Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract Levodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐do

Treatment of levodopa-induced dyskinesia

✍ Jayaraman Rao 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 672 KB

Levodopa-induced dyskinesia: clinical ob

Levodopa-induced dyskinesia: clinical observations

✍ Andrzej Friedman 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 315 KB

Mirtazapine reduces levodopa-induced dys

Mirtazapine reduces levodopa-induced dyskinesia

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Molecular mechanisms underlying levodopa

Molecular mechanisms underlying levodopa-induced dyskinesia

✍ Paolo Calabresi; Massimiliano Di Filippo; Veronica Ghiglieri; Barbara Picconi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Although levodopa remains the most effective drug for the symptomatic treatment of Parkinson's disease, chronic therapy with this pharmacological compound initiates a complex cascade of cellular and molecular downstream effects resulting in the development of abnormal involuntary movements. The prec